CN1047089C - Hypopsia recovering medicine and preparing process - Google Patents
Hypopsia recovering medicine and preparing process Download PDFInfo
- Publication number
- CN1047089C CN1047089C CN93114830A CN93114830A CN1047089C CN 1047089 C CN1047089 C CN 1047089C CN 93114830 A CN93114830 A CN 93114830A CN 93114830 A CN93114830 A CN 93114830A CN 1047089 C CN1047089 C CN 1047089C
- Authority
- CN
- China
- Prior art keywords
- radix
- fructus
- chinensis
- medicine
- cortex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a medicinal preparation prepared from plants and a preparation technology thereof, particularly to a hypopsia recovering medicine which is composed of 20 to 30g of matrimony vine, 60 to 70g of slenderstyle acanthopanax bark, 40 to 50g of aleppo avens herb, 10 to 20g of schisandra fruit, 60 to 70g of rhizoma polygonati, 100 to 120g of Aralia chinensis L, 100 to 120g of yellowflower milkwort root, 40 to 50g of tuber fleeceflower stem, 20 to 30g of yunnan madder root, 40 to 50g of tuckahoe, 40 to 50g of hawthorn, 10 to 20g of flos chrysanthemi from Hangzhou of China, 10 to 20g of shave grass and 10 to 20g of grassleaf sweetflag rhizome.
Description
The present invention relates to the medicinal preparation and the preparation technology that derive from the short, bristly hair or beard thing.
At present, roughly can divide three classes for bathomorphic treatment: one, collyrium treatment; Two, oral tablets treatment; Three, operative treatment." the JINSHILING sheet " that the treatment myopia oral tablets of present domestic public use has punishment tableland district pharmaceutical factory to produce, form by Rhizoma Acori Graminei, Radix Polygalae, Folium Mori, Herba Centipedae etc., " brightening piece " that Hubei governor sun county pharmaceutical factory produces is by forming Radix Codonopsis, Fructus Lycii, Radix Angelicae Sinensis, Radix Polygalae, Radix Ophiopogonis.
Purpose of the present invention aims to provide a kind of myopia limit treatment tablet with health role and the production technology of this tablet.
The bathomorphic medicine of treatment of the present invention is made with following raw materials in weight: Fructus Lycii 20-30g, Cortex Acanthopancis 60-70g, Radix seu Herba Gei aleppici 40-50g, Fructus Schisandrae Chinensis 10-20g, Rhizoma Polygonati 50-70g, Cortex araliae chinensis 100-120g, Radix polygalae arillatae 100-120g, Caulis Polygoni Multiflori 40-50g, Radix Rubiae Yunnanensis 20-30g, Poria 40-50g, Fructus Crataegi 4050g, Flos Chrysanthemi 10-20g, Herba Equiseti Hiemalis 10-20g, Rhizoma Acori Graminei 10-20g.
Fructus Lycii is the dry mature fruit of plant of Solanaceae lycium barbarum Lycuim bar barum L., and Cortex Acanthopancis is the dry root bark of Araliaceae acanthopanax gracilistylus Acanthe panax graclistylus W.W.Smith: Radix seu Herba Gei aleppici is the dry herb of rosaceous plant Fructus Adinae Geum japonicum Thunb.Var.chinense Bolle; Fructus Schisandrae Chinensis is the drying and ripening fruit of magnoliaceae schisandra Schisandra chinensis (Turcz) Bail or schisandra chinensis S.sphenanthera Rehd.et Wils; Rhizoma Polygonati is the dry rhizome of liliaceous plant Yunnan Rhizoma Polygonati Polygonatum Kingianum Coll.et Hemsl. Rhizoma Polygonati P.sibircum Red or Polygonatum cyrtonema Hua P.cvrtonema Hua; Cortex araliae chinensis is dry root and the stem that Wu adds the Zhi Wu of section Cortex araliae chinensis Aralia chinensis.L.; Radix polygalae arillatae is dry root and the stem of milk wort Radix polygalae arillatae Polygala arillata Buch-ham.; Caulis Polygoni Multiflori is the dry rattan of polygonum multiflorum thunb Polygonum multiflorum Thunb; Radix Rubiae Yunnanensis is the dry root and rhizome of Maguireothamnus speciosus Radix Rubiae Yunnanensis Rubia yunnanensis (Franch) Diels; Poria is the dry sclerotia of Polyporaceae fungus Poria poria cocos (schw) wolf; Fructus Crataegi is the dry mature fruit of rosaceous plant Fructus Crataegi cuneatae Crataegus cuneata sieb etzuocr, and Flos Chrysanthemi is the dry headdress flower inflorescence of feverfew chrysanthemum Chrysanthemum morifolium Ramat.; The Herba Equiseti Hiemalis is the dry aerial parts of Equisetaceae plant Herba Equiseti Hiemalis Equisetum hiemale I.; Rhizoma Acori Graminei is the dry rhizome of acorus gramineus araceae plant Acorus tatarinowii schott.
During the bathomorphic medicine of treatment of the present invention is formed, Fructus Lycii nourishing the liver and kidney, replenishing vital essence to improve eyesight; Cortex Acanthopancis invigorating the liver and kidney, bone and muscle strengthening; The Radix seu Herba Gei aleppici enriching yin and nourishing kidney, make eye bright, the Fructus Schisandrae Chinensis tonifying kidney for improving eyesight; Rhizoma Polygonati tonifying liver gas, make eye bright; Close invigorating liver and kidney and make eye bright and be monarch drug.The Cortex araliae chinensis invigorating QI and tranquilization, strong smart nourishing kidney; The Radix polygalae arillatae Fructus Alpiniae Oxyphyllae of calming the nerves, QI invigorating; The Caulis Polygoni Multiflori tranquilizing by nourishing the heart; Three gas of building up one's health by taking tonic are calmed the nerves, and the heart nourishing and intellengence improving is a ministerial drug to help order bright.Radix Rubiae Yunnanensis is enriched blood and is invigorated blood circulation, Poria spleen invigorating mind calming, Fructus Crataegi dissipating fluid-retention food strengthening the spleen and stomach, and three blood of building up one's health by taking tonic are invigorated blood circulation, and strengthening the spleen and stomach is an adjuvant drug to augment the foundation of acquired constitution.Flos Chrysanthemi, Herba Equiseti Hiemalis's suppressing the hyperactive liver make eye bright, and that Rhizoma Acori Graminei is regulated the flow of vital energy is sensible, making eye bright is messenger drug.So medicine-feeding the monarch and his subjects assistant is share, and belongs to order on the QI and blood regulating, play nourishing the liver to improve visual acuity altogether, the effect of the Fructus Alpiniae Oxyphyllae of calming the nerves.
The preparation technology of the bathomorphic medicine of treatment of the present invention is made up of following step:
(1), getting Fructus Lycii, Fructus Schisandrae Chinensis, Rhizoma Polygonati, Radix Rubiae Yunnanensis, Poria, Rhizoma Acori Graminei powder is smalls;
(2), Cortex Acanthopancis, Radix seu Herba Gei aleppici, Cortex araliae chinensis, Radix polygalae arillatae, Caulis Polygoni Multiflori, Fructus Crataegi, Flos Chrysanthemi, Herba Equiseti Hiemalis are merged, decoct with water 1-2 hour, filter, repeatedly for several times, merging filtrate, being evaporated to proportion is 1.28 ± 0.2:
(3), step () gains are mixed with step (two) gains, mix well, granulate, compacting in flakes, packing.
In the above-mentioned steps, owing to Fructus Lycii, Fructus Schisandrae Chinensis, Rhizoma Polygonati, the pharmacological action of Radix Rubiae Yunnanensis, Rhizoma Acori Graminei is better, and its pulverizing is taken with the fecula form, is able to whole utilizations to guarantee active ingredient.(grinding general thin) to-120 orders, it is because it has the effect that absorbs extractum and disintegrating agent that Poria also uses with full powder, makes that whole tablet disintegrate is easy; It is strong that the described medicines of step (two) such as Radix polygalae arillatae, Cortex araliae chinensis, Radix seu Herba Gei aleppici mostly are fibroid, and body constitution is gently steeped, and wooden part accounts for most medical material, and active ingredient is all water-soluble, is advisable to boil to carry, and generally boils to carry three times and get final product.
The medicine raw material of the bathomorphic medicine of treatment of the present invention is easy to get, compatibility is reasonable, and preparation technology is simple, prove through acute toxicity test and long term toxicity test, this medicine is safe in utilization, and it is with health role, through over 5 years 28000 many cases vision decline persons having been carried out the clinical verification observation, recent recovery rate to teenage pseudomyopia can reach 100%, various myopes' total effective rate reaches 98%, wherein produce effects (controlling the back vision improves more than the c chart triplex row) 38.5%, effectively (controlling the back vision improves more than c chart two row) 50%, clinical recovery 9.5%, invalid 2%.
Embodiment:
Get Fructus Lycii 20g, Fructus Schisandrae Chinensis 10g, Rhizoma Polygonati 60g, Radix Rubiae Yunnanensis 20g, Rhizoma Acori Graminei 10g, Poria 40g decontamination, oven dry, powder is to-120 orders, Cortex Acanthopancis 60g, Radix seu Herba Gei aleppici 40g , Cortex araliae chinensis 120g, Radix polygalae arillatae 120g, Radix Polygoni Multiflori Teng 40g, Fructus Crataegi 40g, Flos Chrysanthemi 10g, Herba Equiseti Hiemalis 10g decocting in water three times, each 1-2 hour, boil after-filtration, filtrate merges, reduce pressure extractum, aforementioned powder and extractum are mixed, granulate, repress is made the tablet of 0.2g, and packing gets final product behind the sugar coating.
The tablet character: after removing sugar-coat, the sheet heart shows sepia, flavor slightly if, little sweet.
This tablet is rich in trace element, and test result is as follows:
Table 1 unit: μ g/g
Constituent content constituent content constituent content
Zn 61.8 Cu 20.1 Fe 1068
Mn 88. Ni 3.36 Sr 40.9
Ba 136 Mg 2858 Al 1040
S 3071 P 1594 K 19292
Na 1216 V 2.86 Ti 115
Cr 6.5 Ca 4106 Si 136
Co 1.9 mono (rare earth element) 5.43
This tablet contains several amino acids, and test result is as follows:
Table 2 unit: %
The sample title is treated bathomorphic medicine
ASP aspartic acid 0.54
THR threonine 0.10
SER serine 0.13
GLU glutamic acid 0.58
The sample title is treated bathomorphic medicine
PRO proline 0.15
GLY glycine 0.14
ALA alanine 0.17
VAL valine 0.19
ILE isoleucine 0.08
LEU leucine 0.26
TYR tyrosine 0.07
PHE phenylalanine 0.09
LYS lysine 0.06
NH3 ammonia 0.34
HIS histidine 0.03
ARG arginine 0.16
Claims (2)
1, the bathomorphic medicine of a kind of treatment, it is characterized in that making: Fructus Lycii 20-30g, Cortex Acanthopancis 60-70g, Radix seu Herba Gei aleppici 40-50g, Fructus Schisandrae Chinensis 10-20g, Rhizoma Polygonati 60-70g Cortex araliae chinensis 100-120g, Radix polygalae arillatae 100-120g, Caulis Polygoni Multiflori 40-50g, Radix Rubiae Yunnanensis 20-30g, Poria 40-50g, Fructus Crataegi 4-50g, Flos Chrysanthemi 10-20g, Herba Equiseti Hiemalis 10-20g, Rhizoma Acori Graminei 10-20g with following raw materials in weight.
2, according to the preparation technology of the bathomorphic medicine of the described treatment of claim 1, it is characterized in that forming by following steps:
(1), getting Fructus Lycii, Fructus Schisandrae Chinensis, Rhizoma Polygonati, Radix Rubiae Yunnanensis, Poria, Rhizoma Acori Graminei powder is smalls;
(2), Cortex Acanthopancis, Radix seu Herba Gei aleppici, Cortex araliae chinensis, Radix polygalae arillatae, Caulis Polygoni Multiflori, Fructus Crataegi, Flos Chrysanthemi, Herba Equiseti Hiemalis are merged, decoct with water 1-2 hour, filter, decoct three times, merging filtrate, being evaporated to proportion is 1.28+0.2;
(3), step () gains are mixed with step (two) gains, mix well, granulate, compacting in flakes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN93114830A CN1047089C (en) | 1992-12-03 | 1993-11-18 | Hypopsia recovering medicine and preparing process |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN92114381 | 1992-12-03 | ||
CN92114381.8 | 1992-12-03 | ||
CN93114830A CN1047089C (en) | 1992-12-03 | 1993-11-18 | Hypopsia recovering medicine and preparing process |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1088451A CN1088451A (en) | 1994-06-29 |
CN1047089C true CN1047089C (en) | 1999-12-08 |
Family
ID=25742867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN93114830A Expired - Lifetime CN1047089C (en) | 1992-12-03 | 1993-11-18 | Hypopsia recovering medicine and preparing process |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1047089C (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5689117B2 (en) * | 2009-06-12 | 2015-03-25 | ジェネレックス ファーマシューティカルズ インコーポレイテッド | Compositions and methods for preventing and treating heart failure |
US8586106B2 (en) | 2011-12-06 | 2013-11-19 | The Concentrate Manufacturing Company Of Ireland | Fatigue-relieving herbal extracts and beverages comprising the same |
-
1993
- 1993-11-18 CN CN93114830A patent/CN1047089C/en not_active Expired - Lifetime
Non-Patent Citations (3)
Title |
---|
河北中医1987(2) 1987.2.1 王毅夫,疔明眼丸治疗近视眼300例观察 * |
河北中医1987(2) 1987.2.1 王毅夫,疔明眼丸治疗近视眼300例观察;浙江中医杂志 1988.11.23 丁培植等,治视灵治疗儿童近视眼92例 * |
浙江中医杂志 1988.11.23 丁培植等,治视灵治疗儿童近视眼92例 * |
Also Published As
Publication number | Publication date |
---|---|
CN1088451A (en) | 1994-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101485830B (en) | Pure Chinese medicine anti-aging health-care capsule | |
CN1951481A (en) | Medicament for treating cerebral thrombosis | |
CN1099992A (en) | Nourishing tea | |
KR20030020908A (en) | Cosmetic composition using fermentation of natural herb medicine | |
CN106620609A (en) | Hair regeneration formula and preparation method for same | |
CN1087267A (en) | A kind of prescription for the treatment of seborrheic alopecia | |
CN104138529A (en) | Traditional Chinese medicine preparation capable of reducing blood lipid and preparation method of Traditional Chinese medicine preparation | |
CN108095078A (en) | Strengthen immunity fatigue-relieving composition and preparation method thereof | |
CN1047089C (en) | Hypopsia recovering medicine and preparing process | |
CN100579554C (en) | Medicament for treating protrusion of intervertebral disc and preparation method thereof | |
CN1091963A (en) | Freckle-removing beauty drug | |
CN105797034A (en) | Method for preparing traditional Chinese medicinal composition for treating steatohepatitis complicated with hyperlipidemia | |
CN1240655A (en) | Face-nursing stigma croci tea and its making method | |
CN1174766C (en) | Chinese medicine beautifying pellet and its compounding process | |
CN1425456A (en) | Nourishing wine for regulating human body balance function | |
CN1077127A (en) | Incense circuit health magic liquid and preparation technology thereof | |
CN1050293C (en) | Ant composite and its preparation | |
CN108186874B (en) | A Chinese medicinal composition for treating diabetes | |
CN1302635A (en) | Medical capsule for dredging channels and lowering blood pressure and its preparing process | |
CN1069531C (en) | Chinese medicine compositions and preparation for prevention and treatment of cerebrovascular atherosclerosis and cancer | |
CN1739718A (en) | Kidney invigorating yurong oral liquid and its prepn | |
CN105685306A (en) | Tea with immune regulating function and preparing method of tea | |
CN114832064A (en) | Whitening and freckle removing mask and preparation method thereof | |
CN1194732C (en) | Chinese herbal medicine for treating coronary heart disease and angina pectoris and its prepn | |
CN104288680A (en) | Liver-protecting and heart-nourishing tablet and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CX01 | Expiry of patent term |
Expiration termination date: 20131118 Granted publication date: 19991208 |